Cornelia Ottiger and Andreas R. Huber * Analytical Techniques. Clinical Chemistry 49: (2003) Automation and

Size: px
Start display at page:

Download "Cornelia Ottiger and Andreas R. Huber * Analytical Techniques. Clinical Chemistry 49: (2003) Automation and"

Transcription

1 Clinical Chemistry 49: (2003) Automation and Analytical Techniques Quantitative Urine Particle Analysis: Integrative Approach for the Optimal Combination of Automation with UF-100 and Microscopic Review with KOVA Cell Chamber Cornelia Ottiger and Andreas R. Huber * Background: Automated systems have enabled the counting of particles in urine to be standardized. Their superiority over traditional sediment analysis has been well documented, but they have not gained wide acceptance. The reasons for this are that sediment analysis has been performed and interpreted for decades. Additionally, pathologic casts and other unknown particles still must be confirmed under the microscope. Furthermore, comparison between the methods has revealed outliers and thus decreased confidence in automation. Methods: We used the standardized KOVA cell chamber system to count particles and compared the results with UF-100 flow cytometry as an alternative to traditional sediment analysis. Results: We compared 252 randomly selected urine samples and obtained a review rate of 33%. Microscopic verification was necessary because of the presence of casts, yeast, sperm, dysmorphic erythrocytes, and some misclassified erythrocytes or leukocytes that were detected by incongruent dipstick results and abnormal scattergrams. We obtained correlation coefficients of for erythrocytes and for leukocytes. Criteria for an algorithm to identify samples that needed microscopic review were derived from comparisons between the number of particles from UF-100, dipstick results, cell chamber counting, and sediment analysis. Conclusions: Automated cell counting combined with microscopic counting with a standardized cell chamber system is useful. An objective algorithm for review criteria can be developed via systematic comparison of UF-100 flow cytometry and microscopy. Only urine samples that meet these criteria need to be confirmed microscopically American Association for Clinical Chemistry Microscopic sediment analysis is still used world-wide to examine cells and particles in the urine, but its limited precision (1) and the large amount of manual labor are drawbacks. Standardization of urinalysis has been recommended by the NCCLS and the European Urinalysis Guidelines (2 4) with use of an automated system or a standardized procedure to count the cells in a chamber within a predefined volume. Flow cytometry allows for more precise counting of particles in the urine than does traditional sediment analysis (5 7). Previous studies that compared the Sysmex UF-100 (TOA Medical Electronics) with microscopy and dipstick results found a good correlation between the methods (8). On the other hand, some outliers were seen in these studies but were never systematically examined (9). Additionally, the identification of pathologic casts and other unknown particles still requires confirmation by microscopy, which is usually performed by traditional sediment analysis, a semiquantitative method. The aim of this study was to determine the microscopic review rate from randomly selected urine samples in a general tertiary care hospital after a simultaneous dipstick measurement with a dipstick reader and automated counting of particles by the UF-100 flow cytometer. Our aim was to establish an algorithm for positive selection of those urine samples that need microscopic confirmation. The benefits of such an algorithm would be a considerable reduction in manual labor and optimization of the workflow without any loss of sensitivity and specificity. The Department of Laboratory Medicine, Kantonsspital Aarau, CH-5001 Aarau, Switzerland. *Author for correspondence. andreas.huber@ksa.ch. Received September 10, 2002; accepted January 9, Nonstandard abbreviations: RBC, red blood cell; WBC; white blood cell; EC, squamous epithelial cell; SRC, small round cell; and HPF, high power field. 617

2 618 Ottiger and Huber: Quantitative Urinalysis with UF-100 plus KOVA Chamber UF-100 flow cytometer was compared with the disposable KOVA cell chamber system (Hycor) (10, 11) and traditional urine sediment analysis. From our results, we propose a standard approach for counting particles in urine that uses the flow cytometer and/or the KOVA cell chamber with the advantage that laboratories of all sizes could integrate one or both methods. Materials and Methods uf-100 flow cytometer We randomly selected 268 urine samples from different departments of our hospital (e.g., medicine, surgery, gynecology, nephrology, and intensive care) and analyzed them microscopically (see below) and with the UF-100 (software version 12; Digitana), as described by the manufacturer. Samples were analyzed within 1 h of arrival. We analyzed 10 samples three to five times with the UF-100 for precision measurements. The number of red blood cells (RBCs), white blood cells (WBCs), squamous epithelial cells (ECs), and other particles were counted in 252 samples. Dipstick results were obtained for all of the urine samples. Blood and leukocyte esterase from the dipsticks and particle counting with the KOVA cell chamber and traditional sediment analysis (see below) were compared with results for RBCs and WBCs from the UF-100 and assessed for concordant/discordant results. Discordant results were defined when the number of RBCs above the cutoff, as measured by the UF-100, was at least two times higher than the number counted in the KOVA cell chamber, when the RBC scattergram was abnormal, or when the dipstick results for blood or leukocyte esterase did not match with the number of RBCs and WBCs, respectively. An incongruent result was defined as follows: (a) the semiquantitative dipstick result was negative/trace and the cell number in the KOVA chamber was 10, but the cell count with UF-100 was 21 and up to /L; (b) samples with a positive dipstick result whose cell count was more than twice as high on the KOVA system as on the UF-100, or vice versa, and had, in addition, an abnormal scattergram and/or a flag. Particles such as casts, small round cells (SRCs), yeast, sperm, crystals, and dysmorphic RBC were taken into account because a large number of these particles can influence the classification of cells in the scattergram (5, 12, 13). The reason for each discordant result was determined (e.g., influence of yeast, sperm, or crystals on RBC). The lowest number of each influencing particle that produced discordance was derived for the algorithm accordingly (see Results). microscopy with kova cell chamber and sediment analysis The KOVA system was selected as an alternative microscopic method because it provides a standardized quantitative procedure like the UF-100. The KOVA system includes a conical graduated test tube, in which the urine is centrifuged; the KOVA Petter, a disposable plastic transfer pipette constructed with a bulb-like base, which allows easy and precise decanting of the supernatant; and 10 chambers with grids on one disposable KOVA slide (10). From the urine samples mentioned above, we counted six urine specimen five times in the KOVA cell chamber to assess precision. The same 252 samples assayed by UF-100 were analyzed in parallel with the KOVA system (Axon Lab) and the traditional urine sediment analysis. After the urine was analyzed with the UF-100, the remainder was centrifuged at 400g for 5 min (2). The total urine volume in the conical 8-mL Vacutainer urine tubes (BD Allschwil), which replaced for practical reasons (pneumatic transport system) the original KOVA tubes, was measured against a reference tube. The supernatant was removed with the KOVA Petter after centrifugation, and the volume of the remaining urine in the tube was measured with an Eppendorf pipette, giving a mean (SD) of (0.05) ml. The pellet was mixed well with the KOVA Petter, and one drop was placed in the KOVA cell chamber. Irrespective of the UF-100 results, microscopic evaluation took place and was always performed by the same person. The microscopic counting with phase contrast for the detection of dysmorphic RBCs was done after cells were allowed to settle for 5 min. For counting in the KOVA chamber, the middle section in the grid was chosen, and RBCs, WBCs, and ECs were counted at a 400 magnification in 10 small squares. Other particles were evaluated qualitatively in the low power field at 100 magnification. The number of cells was calculated according to the equation below: n Vol Cells 10 6 Centr /L Vol Chamber Vol Tube where n is the number of cells counted in 10 small squares, Vol Centr is the volume of the pellet after centrifugation, Vol Tube is the total volume of urine in the test tube, and Vol Chamber is the volume of 10 small squares ( L). Another drop was placed on a glass slide and covered with a mm coverslip for traditional urine sediment analysis. For the urine sediment analysis, several high power fields (HPFs) were estimated, and the counts were given as an average per HPF. These values were normalized to a given volume: Cells 10 6 /L n Vol Centr Vol Slide HPF Slide Vol Tube where n is the average number of cells per HPF, and HPF Slide is the ratio of the area of the slide and the area of one HPF, i.e., (20 mm) 2 / (0.175 mm) 2. Vol Slide is the volume under the coverslip ( L) (2).

3 Clinical Chemistry 49, No. 4, dipstick To compare chemical dipstick results (Multistix 10 SG; Bayer) for RBCs and WBCs with those obtained with the UF-100 flow cytometer, all urine samples were analyzed with an automatic dipstick reader (Clinitec Atlas; Bayer). statistics Regression analysis to establish differences between the methods was performed with Deming systematic difference calculations (14). Results that were flagged for review by the UF-100 (Fig. 4), incongruent dipstick results, abnormal scattergrams, urine samples with a volume 5 ml, and samples that had to be diluted because of very high cell numbers were excluded from the regression analysis. Results comparison of uf-100 with kova system We analyzed 252 urine samples and compared the results obtained with the UF-100 and the KOVA system. We included 212 results for RBCs and 241 results for WBCs in the general Deming regression analysis, a weighted leastsquares regression model (14). The remaining samples were excluded from the regression analysis because of flags from the UF-100, incongruent dipstick results, or abnormal scattergrams (see below). Fig. 1 shows the correlation of RBCs and WBCs between the two methods. The Deming regression for RBCs was calculated in the range of 0 to cells/l between the KOVA and UF-100 (r 0.966). The regression for WBCs was calculated in the range of 0 to cells/l between the two methods (r 0.935). Additionally, ECs were compared between UF-100 and the KOVA system (r 0.902; Table 1). RBC and WBC results were also compared with the traditional sediment estimation. From the average number of cells/hpf, values with cells 10 6 /L were calculated. The correlation was for RBCs and for WBCs, respectively (Table 1). precision of uf-100 and kova system Internal quality control of the UF-100 was done with a mixture of latex particles. Interassay imprecision (CV) for 43 measurements was 4.1% at a mean of RBC/L, 2.8% at WBC/L, and 7.2% at BACT (bacteria 2 m)/l. To compare the two methods, precision measurements for RBCs and WBCs were performed with low, intermediate, and high cell numbers with the UF-100 flow cytometer and the KOVA cell chamber system (Fig. 2). SDs were slightly higher for the KOVA system than for the UF-100. As expected, the CV decreased with increasing numbers of cells and asymptotically approached 10% for UF-100 and 15% for the KOVA system. Because the UF-100 (software version 12) enumerates two different bacterial particles, BACT (bacteria 2 m) and H-BACT (bacteria 2 m), the SDs were 1 11 Fig. 1. Deming regression analysis (14) for RBCs (A) and WBCs (B) between the KOVA system and the UF-100. We included 212 results for RBCs and 241 results for WBCs in the regression from a total of 252 urine samples. Regression statistics were: for RBCs, y 1.16x /L (r 0.966); for WBCs, y 1.50x /L (r 0.935) /L for BACT in the range of /L and /L for H-BACT in the range of /L, i.e., the CV was 2 5%. review rate In previous studies, outliers for RBCs and WBCs between the UF-100 and cell chamber counting were noted but not Table 1. Deming regression analysis for RBCs, WBCs, and ECs in urine. KOVA vs UF-100 a Sediment vs UF-100 a RBCs (n 212 samples) b Slope 1.16 (0.02) 0.88 (0.02) Intercept, 10 6 /L 4.3 (1.26) 1.25 (1.58) Correlation coefficient WBCs (n 241 urine samples) b Slope 1.50 (0.04) 1.15 (0.04) Intercept, 10 6 /L 4.4 (1.39) 1.75 (1.70) Correlation coefficient ECs (n 46 urine samples) b Slope 1.26 (0.09) Intercept, 10 6 /L 1.9 (3.22) Correlation coefficient a SD of slope and intercept in parentheses. b Of a total of 252 samples.

4 620 Ottiger and Huber: Quantitative Urinalysis with UF-100 plus KOVA Chamber Fig. 2. Precision of RBC (A) and WBC (B) counts with the UF-100 ( ) and the KOVA system ( ). In the UF-100, each sample was measured three to five times. In the KOVA chamber, for each data point, five aliquots from one centrifuged tube were added to the chamber and counted. specifically examined (8, 9). Our work therefore was initiated to explore the causes of the differences and to obtain an estimate of the fraction of samples requiring microscopic confirmation. Results from 168 (66.7%) of 252 samples were correctly interpreted by UF-100 and would not have needed further evaluation (Fig. 3). Of the remaining 84 samples (33.3%), 23 (9.1%) had to be checked microscopically for casts, SRCs, and high numbers of crystals, yeast, and sperm Fig. 3. Classification of results for 252 urines after analysis with UF-100. Review rate from the interpretation of scattergrams together with results from microscopy and dipstick. cells because classification of RBCs may be influenced by these particles. However, we found that in these cases interference with RBC and WBC counts did not occur and that 6 of 23 samples that contained yeast, sperm, or crystals above the review limits (Fig. 4) were selected unnecessarily. In these six samples, the particles did not overlap with the RBC gate in the scattergram. The presence of pathologic casts or other particles was not confirmed in one-half of the cases because high numbers of hyaline casts, ECs, and cell debris also can cause such flags. A total of 30 samples (11.9%) with RBC concentrations /L that were flagged for dysmorphic erythrocytes needed microscopic review because we observed that for seven cases in this study, such flags were the only indication of the incorrect counting of RBCs. In 31 samples (12.3%), a review flag from the UF-100, an abnormal distribution of the RBC cloud in the scattergram, or an incongruent dipstick result (see Materials and Methods) for blood or leukocyte esterase made it necessary to recount the cells with the microscope. In all of these cases, the RBC count obtained with the UF-100 was incorrect (Fig. 5), and in five cases, both the RBC and WBC counts were incorrect. RBCs were misclassified when a high amount of bacteria, crystals, sperm, or yeast overlapped with the RBC gate in the scattergram; these particles therefore contributed to erroneously high RBC counts. The presence of naked EC nuclei led to an incorrectly high WBC count. algorithm for microscopic review Ultimately, this study allowed us to determine whether we could find an objective algorithm for screening urine samples that need further confirmation by microscope after combined analysis with the chemical dipstick and counting of particles with the flow cytometer. To achieve this, we adapted the review conditions of the UF-100, originally proposed by the manufacturer. In the proposed algorithm (Fig. 4), we included such items as the cross-check between negative dipstick results and high cell count with the UF-100 (Fig. 5), abnormal scattergrams, undefined or a very high number of particles, RBC information, pathologic casts, SRCs, crystals, yeast, and sperm, whereas conductivity ensured authentic samples in cases of drug abuse. All samples were evaluated for abnormal distribution of the scattergrams and were checked for incongruent results between the dipstick, UF-100, and KOVA system (see Materials and Methods). In those cases in which a particular particle influenced the result, the number of such particles was noted as the limiting factor. Among all such detected samples, the lowest particle number that was found to give no further influence on the scattergram was then used as the review limit in the algorithm. When we examined the data with the proposed algorithm, we found that 6 of 252 samples (2.4%) were selected unnecessarily. However, more importantly, all

5 Clinical Chemistry 49, No. 4, Fig. 4. Review criteria for UF-100 results to be checked by microscopy. Left, settings that can be adjusted on the instrument. Path. Cast, pathologic casts; X tal, crystals; YLC, yeast. Right, variables that have to be considered. Hb/Prot/Lc/Nitrite, hemoglobin, protein, leukocyte esterase, and nitrite from the dipstick. Total particle count (to dilute if ) and conductivity (check composition of specimen) need review if there are persistent flags. samples that needed confirmation were selected by the algorithm. Two circumstances were critical for determining inappropriate classification of RBCs and WBCs. The first circumstance, incongruent results between the dipstick and flow cytometer, especially the absence or a low concentration of blood or hemoglobin on the dipstick and a high number of RBCs in the scattergram (Fig. 5), gave evidence for false classification of these particles. The second, samples with dysmorphic RBCs /L, needed to be checked by microscope to avoid missing important renal diseases. In these cases, not only did the number and appearance of the RBCs need to be verified, but RBCs were sometimes wrongly classified and other particles, such as pathologic casts, that had not been flagged by the instrument were detected. Discussion We found an excellent correlation between the KOVA cell chamber and UF-100 for RBCs (r 0.966), WBCs (r 0.935), and ECs (r 0.902). Interestingly, under the condition of a standardized preparation of the traditional sediment analysis within a definite volume, the correlation was still for RBCs and for WBCs. Sediment analysis has to be regarded as a semiquantitative method. We therefore propose that standard counting of particles in urine with the UF-100 flow cytometer in concordance with the KOVA cell chamber system be introduced to fulfill the recommendations of international guidelines (2, 3). Minor deviations between the two systems have to be considered, e.g., the slopes and intercepts in the regression analysis showed differences from 1 and 0, respectively (Table 1). The intercepts of 4 to cells/l are caused by overestimation by the flow cytometer as a result of an overlapping area in the RBC gate in the scattergram. A conversion factor should be introduced if both methods are used in concert and if the same reference values as proposed (8) are accepted. It must be emphasized that the number of cells found in the sample can be affected not only by the method of counting, but also by the test tube (12, 15), to which cells, casts, and

6 622 Ottiger and Huber: Quantitative Urinalysis with UF-100 plus KOVA Chamber Fig. 5. Abnormal scattergrams of discordant RBC counts between the KOVA system, UF-100, and dipstick results. Negative ( ), trace (f), (E), 2 (F), and 3 ( ) results were evaluated. In all of these samples, high amounts of bacteria, crystals, yeast, and sperm disturbed the RBC classification. other particles can adsorb, and by transportation and centrifugation, during which mechanical forces and temperature can destroy the particles (1). Therefore, the systematically lower values obtained with the KOVA chamber might explain the differences between our findings and those of Okada et al. (16), who compared the UF-50 and the KOVA chamber filled with uncentrifuged urine. However, because of the small number of cells in the chamber, their precision measurements above the cutoff gave CVs up to 57%. The intraassay CV for patient samples measured by UF-100 was 10% for both RBCs and WBCs above the cutoff of cells/l. With the KOVA chamber, we obtained slightly higher CVs, up to 15%. This is because we counted a much smaller number of cells microscopically than were counted by the UF-100. Bacteria were counted by UF-100 with high precision (CVs 5%). Flow cytometry for bacterial counting has been recommended for use in the screening of urinary tract infections because its sensitivity is 55% and its specificity is 90% (13). To evaluate a unifying system, we compared the flow cytometer, the dipstick method, and the KOVA system in 252 urine samples. The flow chart in Fig. 4 shows the criteria for a microscopic review. A total review rate of 33% (Fig. 3) was obtained, with 9% of the reviews attributable to flags for casts, SRCs, crystals, yeast, and sperm. Clumped ECs often gave a flag for pathologic casts and SRCs; they therefore need to be confirmed. Large numbers of crystals, yeast, and sperm cells are known to overlap with the RBC gate in the scattergram and may lead to misclassification. This is the main reason to check the number of RBCs by microscope. However, RBCs and WBCs from this group were correctly interpreted by the UF-100 and were not falsely classified. We found dysmorphic RBCs cells/l in 12% of all urine samples. Considering this flag, 2.8% of all urine samples were misclassified for RBC count. Additionally, the presence of dysmorphic erythrocytes could not be confirmed in all cases by microscopy because there is an overlapping area between normal and dysmorphic RBCs in the RBC Fsc graph of the UF-100. The testing was done with UF-100 software version 12. Although the version has been upgraded to 18 and the differentiation of dysmorphic RBC has been improved, we have not found major changes. In 12% of all samples, RBCs, and in some cases both RBCs and WBCs, were incorrectly classified by the UF-100 (Fig. 5) and thus would have given rise to false results if no attention has been paid to the review criteria (Fig. 4). The reason for the incorrect classification of RBCs was mainly the presence of crystals, yeast, sperm, and a large number of bacteria, as already pointed out by others (12, 13). The selecting gate for RBCs in the scattergram overlaps partly with these particles. One reason for WBC misclassification was the presence of naked EC nuclei. Urine samples from nephrology departments will show higher review rates from flags for casts and dysmorphic RBCs. This could explain the differences in published review rates, 6 35% (7). Expert systems seemed to improve the reliability of results, thereby decreasing microscopic reviews (7, 17). However, it seems that solving the technical details of the urine analysis before using such a system may not have been taken into consideration in these studies. Application of the review criteria (Fig. 4) enabled complete detection of all samples that had to be confirmed by microscopy. Unnecessary confirmation was done in only 2.4% of all cases. It can be concluded that only samples that fall within these parameters have to be checked microscopically. There is thus no objective reason to analyze urine samples systematically by microscopy just because they contain particles above the reference values. Future development of urinalysis systems should aim to attain accurate and precise measurement of the total number of RBCs, WBCs, and bacteria, taking into account parameters for the urine concentration, such as creatinine or conductivity and differential protein analysis (18, 19). With these additional criteria, a more accurate diagnosis and therapy can be achieved. In conclusion, we believe that standardization of cell counting in urine is possible with the UF-100 and KOVA systems and that both methods can be used in lieu of each other under certain conditions. Our systematically performed comparison between UF-100 and microscopy led to an algorithm for the selection of samples for microscopic review. Only those urine specimens specifically identified need microscopic review. We would like to thank Digitana (Horgen, Switzerland) for their granted support of the flow cytometer. We are grateful for the material provided by Axon Lab (Dättwil, Switzerland) and BD (Allschwil, Switzerland).

7 Clinical Chemistry 49, No. 4, References 1. Winkel P, Statland BE, Jorgensen K. Urine microscopy, an illdefined method, examined by a multifactorial technique. Clin Chem 1974;20: National Committee for Clinical Laboratory Standards. Urinalysis and collection, transportation and preservation of urine specimens; approved guideline. NCCLS document GP 16-A. Wayne, PA: NCCLS, European urinalysis guidelines. Summary. Scand J Clin Lab Invest 2000;60(Suppl 231): Kouri TT, Gant VA, Fogazzi GB, Hofmann W, Hallander HO, Guder WG. Towards European urinalysis guidelines. Introduction of a project under European Confederation of Laboratory Medicine. Clin Chim Acta 2000;297: Fenili D, Pirovano B. The automation of sediment urinalysis using a new urine flow cytometer (UF-100). Clin Chem Lab Med 1998; 36: Hannemann-Pohl K, Kampf SC. Automation of urine sediment examination: a comparison of the Sysmex UF-100 automated flow cytometer with routine manual diagnosis (microscopy, test strips, and bacterial culture). Clin Chem Lab Med 1999;37: Delanghe JR, Kouri TT, Huber AR, Hannemann-Pohl K, Guder WG, Lun A, et al. The role of automated urine particle flow cytometry in clinical practice. Clin Chim Acta 2000;301: Regeniter A, Haenni V, Risch L, Köchli HP, Colombo JP, Frei R, et al. Urine analysis performed by flow cytometry: reference range determination and comparison to morphological findings, dipstick chemistry and bacterial culture results a multicenter study. Clin Nephrol 2001;55: Ben-Ezra J, Bork L, McPherson RA. Evaluation of the Sysmex UF-100 automated urinalysis analyzer. Clin Chem 1998;44: Mahon CR, Smith LA. Standardization of the urine microscopic examination. Clin Lab Sci 1990;3: McGinley M, Lee Wong L, McBride JH, Rodgerson DO. Comparison of various methods for the enumeration of blood cells in urine. J Clin Lab Anal 1992;6: Langlois MR, Delanghe JR, Steyaert SR, Everaert KC, De Buyzere ML. Automated flow cytometry compared with an automated dipstick reader for urinalysis. Clin Chem 1999;45: Kouri TT, Kahkonen U, Malminiemi K, Vuento R, Rowan RM. Evaluation of Sysmex UF-100 urine flow cytometer vs chamber counting of supravitally stained specimens and conventional bacterial cultures. Am J Clin Pathol 1999;112: Martin RF. General Deming regression for estimating systematic bias and its confidence interval in method-comparison studies. Clin Chem 2000;46: [Data supplement. GDR: executable program for general Deming regression calculations and graphics Kim Y, Jin DC, Lee EJ, Lee DH, Chung HH, Kim M, et al. Quantitative analysis of urine sediment using newly designed centrifuge tubes. Ann Clin Lab Sci 2002;32: Okada H, Sakai Y, Kawabata G, Fujisawa M, Arakawa S, Hamaguchi Y, et al. Automated urinalysis. Evaluation of the Sysmex UF-50. Am J Clin Pathol 2001;115: Roggeman S, Zaman Z. Safely reducing manual urine microscopy analyses by combining urine flow cytometer and strip results. Am J Clin Pathol 2001;116: Ivandic M, Hofmann W, Guder WG. The use of knowledge-based systems to improve medical knowledge about urine analysis. Clin Chim Acta 2000;297: Guder WG. Nephrological basis diagnosis in clinical practice. Ther Umsch 1995;52:

Comparison between IRIS iq 200ELITE and microscopy for urinalysis and evaluation of performance in predicting outcome of urine cultures

Comparison between IRIS iq 200ELITE and microscopy for urinalysis and evaluation of performance in predicting outcome of urine cultures Article Reprint Comparison between IRIS iq 200ELITE and microscopy for urinalysis and evaluation of performance in predicting outcome of urine cultures S. Ledru, J.P. Canonne Laboratoire de microbiologie,

More information

Urinalysis: Comparison between Microscopic Analysis and a New Automated Microscopy Image-Based Urine Sediment Instrument

Urinalysis: Comparison between Microscopic Analysis and a New Automated Microscopy Image-Based Urine Sediment Instrument Clin. Lab. 2014;60:693-697 Copyright SHORT COMMUNICATION Urinalysis: Comparison between Microscopic Analysis and a New Automated Microscopy Image-Based Urine Sediment Instrument PAULA V. BOTTINI, MAYARA

More information

True Walkaway Automated Urinalysis, Chemistry to Microscopy The CLINITEK AUWi System Answers for life.

True Walkaway Automated Urinalysis, Chemistry to Microscopy The CLINITEK AUWi System Answers for life. www.siemens.com/diagnostics True Walkaway Automated Urinalysis, Chemistry to Microscopy The CLINITEK AUWi System Answers for life. Can I achieve true unattended urinalysis testing in my laboratory? With

More information

Meets Standards AFTER REVIEW ( 2.5 pts) Fail to meet the standard safety precautions, counseled one time

Meets Standards AFTER REVIEW ( 2.5 pts) Fail to meet the standard safety precautions, counseled one time Morgan State University 2014 MDTC 411 CLINICAL CHEMISTRY AND URINALYSIS PRACTICUM SUGGESTED LABORATORY ROTATION SCORING RUBRIC Please attach the student s test record to this evaluation Clinical Chemistry

More information

Improving the efficiency and efficacy of pre-analytical and analytical work-flow of urine cultures with urinary flow cytometry

Improving the efficiency and efficacy of pre-analytical and analytical work-flow of urine cultures with urinary flow cytometry NEW MICROBIOLOGICA, 31, 501-505, 2008 Improving the efficiency and efficacy of pre-analytical and analytical work-flow of urine cultures with urinary flow cytometry Shamanta Grosso, Graziano Bruschetta,

More information

AAG PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

AAG PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE IMMAGE Immunochemistry Systems Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Alpha 1 -Acid Glycoprotein REF 447780 (150 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by:

More information

Evaluation of the Automated Immature Granulocyte Count (IG) on Sysmex XE-2100 Automated Haematology Analyser vs. Visual Microscopy (NCCLS H20-A)

Evaluation of the Automated Immature Granulocyte Count (IG) on Sysmex XE-2100 Automated Haematology Analyser vs. Visual Microscopy (NCCLS H20-A) Evaluation of the Automated Immature Granulocyte Count (IG) on Sysmex XE-21 Automated Haematology Analyser vs. Visual Microscopy (NCCLS H2-A) Th WEILAND *1, H KALKMAN *2, and H HEIHN *1 *1 Central Laboratory,

More information

APB PRINCIPLE SPECIMEN. REF (300 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

APB PRINCIPLE SPECIMEN. REF (300 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE IMMAGE Immunochemistry Systems Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Apolipoprotein B REF 447730 (300 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed

More information

Total Analytic Error From Concept to Application

Total Analytic Error From Concept to Application Página 1 de 5 Clinical Laboratory News Subscribe CLN Daily CLN Stat CLN Articles Total Analytic Error From Concept to Application Author: James O. Westgard, PhD, and Sten A. Westgard, MS // Date: SEP.1.2013

More information

Screening of urine samples by flow cytometry reduces the need for culture

Screening of urine samples by flow cytometry reduces the need for culture JCM Accepts, published online ahead of print on 30 June 2010 J. Clin. Microbiol. doi:10.1128/jcm.00617-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Ready, Set, Test! AACC Conference Mass Spectrometry in the Clinical Lab: Best Practice and Current Applications September 17-18, 2013 St.

Ready, Set, Test! AACC Conference Mass Spectrometry in the Clinical Lab: Best Practice and Current Applications September 17-18, 2013 St. Ready, Set, Test! Ross Molinaro, PhD, MLS(ASCP) CM, DABCC, FACB Medical Director, Clinical Laboratories Emory University Hospital Midtown Emory Clinical Translational Research Laboratory AACC Conference

More information

WAIT! Ready, Set, Test! Financial Disclosure. Research/Educational grants/consulting/salary support

WAIT! Ready, Set, Test! Financial Disclosure. Research/Educational grants/consulting/salary support Ready, Set, Test! Ross Molinaro, PhD, MLS(ASCP) CM, DABCC, FACB Medical Director, Clinical Laboratories Emory University Hospital Midtown Emory Clinical Translational Research Laboratory AACC Conference

More information

PRINCIPLE SPECIMEN. REF (300 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

PRINCIPLE SPECIMEN. REF (300 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE IMMAGE Immunochemistry Systems Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Complement REF 446450 (300 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by:

More information

CLSI C60: Assay Validation & Post-Validation Monitoring

CLSI C60: Assay Validation & Post-Validation Monitoring CLSI C60: Assay Validation & Post-Validation Monitoring Ross J. Molinaro, MT(ASCP), PhD, DABCC, FACB Medical Director Core Laboratory, Emory University Hospital Midtown Emory Clinical Translational Research

More information

Upon completion of the Clinical Hematology rotation, the MLS student will be able to:

Upon completion of the Clinical Hematology rotation, the MLS student will be able to: Clinical Performance Objectives in Clinical Hematology Department of Medical and Research Technology University of Maryland School of Medicine Spring 2015 Upon completion of the Clinical Hematology rotation,

More information

Harmonization of red blood cell distribution width (RDW): an attainable target?

Harmonization of red blood cell distribution width (RDW): an attainable target? Original Article Page 1 of 5 Harmonization of red blood cell distribution width (RDW): an attainable target? Giuseppe Lippi 1, Silvia Pipitone 2, Emmanuel J. Favaloro 3,4 1 Section of Clinical Biochemistry,

More information

SAMPLE. Urinalysis; Approved Guideline Third Edition

SAMPLE. Urinalysis; Approved Guideline Third Edition February 2009 Urinalysis; Approved Guideline Third Edition This document addresses procedures for testing urine, including materials and equipment; macroscopic/physical evaluation; chemical analysis; and

More information

COMPARISON OF PLATELET COUNTS BY SYSMEX XE 2100 AND LH 750 WITH THE INTERNATIONAL FLOW REFERENCE METHOD IN THROMBOCYTOPENIC PATIENTS

COMPARISON OF PLATELET COUNTS BY SYSMEX XE 2100 AND LH 750 WITH THE INTERNATIONAL FLOW REFERENCE METHOD IN THROMBOCYTOPENIC PATIENTS COMPARISON OF PLATELET COUNTS BY SYSMEX XE 2100 AND LH 750 WITH THE INTERNATIONAL FLOW REFERENCE METHOD IN THROMBOCYTOPENIC PATIENTS TINA DADU 1, KUNAL SEHGAL 2, ANJUM SHAIKH 2, SHANAZ KHODAIJI 2 1. BLK

More information

M-TP PRINCIPLE REF ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

M-TP PRINCIPLE REF ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE SYNCHRON System(s) Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Microprotein REF 445860 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE INTENDED

More information

Automated flow cytometry analysis of peritoneal dialysis fluid

Automated flow cytometry analysis of peritoneal dialysis fluid Nephrol Dial Transplant (2004) 19: 463 468 DOI: 10.1093/ndt/gfg552 Technical Note Automated flow cytometry analysis of peritoneal dialysis fluid Joris Penders 1, Tom Fiers 1, Annemieke M. Dhondt 2, Geert

More information

CR-E PRINCIPLE REF A ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

CR-E PRINCIPLE REF A ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE SYNCHRON System(s) Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Creatinine REF A60298 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE INTENDED

More information

Examples of body fluid analysis with the XE-5000

Examples of body fluid analysis with the XE-5000 Examples of body fluid analysis with the XE-5000 Sysmex Xtra Online March 2011 If patients are to be treated rapidly and effectively, laboratory results must be both rapid and reliable if at all possible,

More information

Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples

Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples Immunopathology / Electrophoresis of Unconcentrated Urine Samples Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples Anja C. Roden, MD,

More information

AAT PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

AAT PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE IMMAGE Immunochemistry Systems Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Alpha 1 -Antitrypsin REF 447740 (150 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed

More information

PAB PRINCIPLE. Kit Reorder # ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

PAB PRINCIPLE. Kit Reorder # ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE SYNCHRON CX System(s) Chemistry Information Sheet Copyright 2008 Beckman Coulter, Inc. Prealbumin Kit Reorder # 475106 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE

More information

LabGuide 13 How to Verify Performance Specifications

LabGuide 13 How to Verify Performance Specifications 1 LG 13 Comments? Feedback? Questions? Email us at info@cola.org or call us at 800 981-9883 LabGuide 13 How to Verify Performance Specifications The verification of performance specifications confirms

More information

EVALUATION OF LIQUID-PREP TM ENCAPSULATION METHOD FOR LIQUID-BASED CYTOLOGY: CELL LOSS ESTIMATES DURING PROCESSING ABSTRACT

EVALUATION OF LIQUID-PREP TM ENCAPSULATION METHOD FOR LIQUID-BASED CYTOLOGY: CELL LOSS ESTIMATES DURING PROCESSING ABSTRACT EVALUATION OF LIQUID-PREP TM ENCAPSULATION METHOD FOR LIQUID-BASED CYTOLOGY: CELL LOSS ESTIMATES DURING PROCESSING James Geyer, Ph.D., James Marino, CMIAC, Fort Lauderdale, FL, USA Seacoast Pathology,

More information

LAM PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

LAM PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE IMMAGE Immunochemistry Systems Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Lambda Light Chain REF 446470 (150 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed

More information

Measurement Uncertainty Guide. ISO Accreditation Program

Measurement Uncertainty Guide. ISO Accreditation Program Measurement Uncertainty Guide ISO 15189 Accreditation Program Background Why This is Necessary The ISO 15189:2012 standard contains enhanced expectations regarding measurement uncertainty (MU) in clause

More information

IGALC PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

IGALC PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE IMMAGE Immunochemistry Systems Chemistry Information Sheet Low Concentration Immunoglobulin A Copyright 2010 Beckman Coulter, Inc. REF 447460 (150 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed

More information

Immature Granulocyte Enumeration Our Journey from Manual to Automated Reporting

Immature Granulocyte Enumeration Our Journey from Manual to Automated Reporting Immature Granulocyte Enumeration Our Journey from Manual to Automated Reporting Mary Capper MT(ASCP)SH Supervisor, Hematology/Hemostasis University of Iowa Hospitals and Clinics Objectives Describe the

More information

Lab: Blood Smear and RBC Count

Lab: Blood Smear and RBC Count 2014-09- 01 Blood Page 1 of 5 Lab: Blood Smear and RBC Count Aim: Learn to count cells, observe and identify different blood cells in a smear, quantify their proportions and count RBCs per µl (mm^3) using

More information

CONCURRENT 10: THE COMPLETE BLOOD COUNT AND BEYOND: QUALITY ISSUES AND REFERENCE METHODS

CONCURRENT 10: THE COMPLETE BLOOD COUNT AND BEYOND: QUALITY ISSUES AND REFERENCE METHODS CONCURRENT 10: THE COMPLETE BLOOD COUNT AND BEYOND: QUALITY ISSUES AND REFERENCE METHODS Saturday May 14 th 2016 1:30 3:00 PM (13.30 15.00hrs) International Society for Laboratory Hematology (ISLH) CONCURRENT

More information

Master. Urinalysis Checklist. CAP Accreditation Program

Master. Urinalysis Checklist. CAP Accreditation Program Master Urinalysis Checklist CAP Accreditation Program College of American Pathologists 325 Waukegan Road Northfield, IL 60093-2750 www.cap.org 08.17.2016 2 of 20 Disclaimer and Copyright Notice On-site

More information

CREA PRINCIPLE SPECIMEN REF ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

CREA PRINCIPLE SPECIMEN REF ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE SYNCHRON System(s) Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Creatinine REF 442760 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE INTENDED

More information

Prepared by Date Adopted Supersedes Procedure # Adapted from HPTN Policy. Review Date Revision Date Signature

Prepared by Date Adopted Supersedes Procedure # Adapted from HPTN Policy. Review Date Revision Date Signature APPENDIX IV: LABORATORY QUALITY CONTROL POLICY Prepared by Date Adopted Supersedes Procedure # Adapted from HPTN Policy N/A Review Date Revision Date Signature Distributed to # of Copies Distributed to

More information

Designing QC Activities to More Precisely Manage Analytical Accuracy and Patient Risk

Designing QC Activities to More Precisely Manage Analytical Accuracy and Patient Risk Designing QC Activities to More Precisely Manage Analytical Accuracy and Patient Risk Curtis A. Parvin, Ph.D. Manager of Advanced Statistical Research Bio-Rad Laboratories, QSD curtis_parvin@bio-rad.com

More information

HST-330 TM and Total Laboratory Automation

HST-330 TM and Total Laboratory Automation HST-330 TM and Total Laboratory Automation Hyun-Sook CHI, MD* * Department of Clinical Pathology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. Total laboratory automation

More information

Common Deficiencies

Common Deficiencies Question text Deficiency #12: Does the laboratory have a documented system to ensure consistency of morphologic observations among all personnel performing (U/A, Micro, Hem) (sample) Suggested methods

More information

Reduction of the Platelet Review Rate Using the Two-Dimensional Platelet Method

Reduction of the Platelet Review Rate Using the Two-Dimensional Platelet Method Coagulation and Transfusion Medicine / REDUCTION OF THE PLTELET REVIEW RTE Reduction of the Platelet Review Rate Using the Two-Dimensional Platelet Method Deanne H. Chapman, MT(SCP)SH, 1 Jonn Hardin, MT,

More information

5 Tips for Better Cell Counting

5 Tips for Better Cell Counting 5 Tips for Better Cell Counting Counting cells is a tedious job that needs to be done properly, be it in industry or academia, be it manually or automated, you want trustworthy results to continue your

More information

Verification or validation, that is the question

Verification or validation, that is the question Perspective Page 1 of 7 Verification or validation, that is the question Giorgia Antonelli 1, Andrea Padoan 1, Ada Aita 1, Laura Sciacovelli 2, Mario Plebani 1,2 1 U.O.C. of Laboratory Medicine, Department

More information

For In Vitro Diagnostic Use

For In Vitro Diagnostic Use SYNCHRON System(s) Chemistry Information Sheet C-Reactive Protein REF (200 tests/cartridge) 465131 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE INTENDED USE reagent,

More information

Successful performance in proficiency testing (PT) is required

Successful performance in proficiency testing (PT) is required Performance Characteristics of Several Rules for Self-interpretation of Proficiency Testing Data R. Neill Carey, PhD; George S. Cembrowski, MD; Carl C. Garber, PhD; Zohreh Zaki, MD Context. Proficiency

More information

MOLECULAR TESTING: VERIFYING/VALIDATING INSTRUMENTS, REAGENTS AND ASSAYS. Richard L. Hodinka, Ph.D.

MOLECULAR TESTING: VERIFYING/VALIDATING INSTRUMENTS, REAGENTS AND ASSAYS. Richard L. Hodinka, Ph.D. MOLECULAR TESTING: VERIFYING/VALIDATING INSTRUMENTS, REAGENTS AND ASSAYS Richard L. Hodinka, Ph.D. University of South Carolina School of Medicine Greenville Greenville Health System, Greenville, SC hodinka@greenvillemed.sc.edu

More information

For In Vitro Diagnostic Use

For In Vitro Diagnostic Use SYNCHRON System(s) Chemistry Information Sheet Lactate Dehydrogenase REF 442660 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE INTENDED USE reagent, when used in

More information

Date. Alkaline phosphatase measurements are used in the diagnosis and treatment of liver, bone, parathyroid, and intestinal diseases.

Date. Alkaline phosphatase measurements are used in the diagnosis and treatment of liver, bone, parathyroid, and intestinal diseases. SYNCHRON CX System(s) Chemistry Information Sheet Copyright 2008 Beckman Coulter, Inc. Alkaline Phosphatase Kit Reorder # 442670 (200 tests/cartridge) Kit Reorder # 476821 (400 tests/cartridge) For In

More information

Automated Hematology System. Your Complete Choice

Automated Hematology System. Your Complete Choice XE-5000 Automated Hematology System Your Complete Choice Advanced Technology Solutions to Meet Your Lab s Needs Even with these challenges, the need for hematology testing has remained steady or continued

More information

Establishing Quality Control Target Values and Standard Deviations for Hematology Instrumentation

Establishing Quality Control Target Values and Standard Deviations for Hematology Instrumentation Establishing Quality Control Target Values and Standard Deviations for Hematology Instrumentation For informational purposes only. WHO REQUIRES IT AND WHAT THEY REQUIRE Regulatory agencies require the

More information

Laboratory Developed Tests. William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center

Laboratory Developed Tests. William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center Laboratory Developed Tests William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center Objectives Compare and contrast new test validation requirements for

More information

Automated Hematology Analyzer. Small Footprint. Big Difference.

Automated Hematology Analyzer. Small Footprint. Big Difference. XS-1000i Automated Hematology Analyzer Small Footprint. Big Difference. Small But Powerful: The XS-1000i Even with these challenges, the need for hematology testing has remained steady or continues to

More information

Date. Albumin measurements are used in the diagnosis and treatment of numerous diseases primarily involving the liver and/or kidneys.

Date. Albumin measurements are used in the diagnosis and treatment of numerous diseases primarily involving the liver and/or kidneys. SYNCHRON System(s) Chemistry Information Sheet Copyright 2013 Beckman Coulter, Inc. Albumin REF 442765 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by Date Reviewed by Date PRINCIPLE INTENDED USE

More information

Validation of Platelet Counting Accuracy With the Celltac F Automated Hematology Analyzer

Validation of Platelet Counting Accuracy With the Celltac F Automated Hematology Analyzer Journal of Automated Methods & Management in Chemistry, 5 (5), no. 4, 35 39 c 5 Hindawi Publishing Corporation Validation of Platelet ing Accuracy With the Celltac F Automated Hematology Analyzer Yutaka

More information

Guideline of the Sector Committee Pathology/Neuropathology for the validation of examination methods in Molecular Pathology

Guideline of the Sector Committee Pathology/Neuropathology for the validation of examination methods in Molecular Pathology Guideline of the Sector Committee Pathology/Neuropathology for the validation of examination methods in Molecular Pathology 71 SD 4 037 Revision: 1.1 04 October 2016 Scope of application: This guideline

More information

XS-1000i New Sysmex 5-part diff haematology analyser with fluorescence technology

XS-1000i New Sysmex 5-part diff haematology analyser with fluorescence technology XS-1000i New Sysmex 5-part diff haematology analyser Fig. 1: sysmex xs-1000i Since the introduction of fluorescence technology for leukocyte differentiation by sysmex in the year 1999, thousands of laboratories

More information

PRINCIPLE SPECIMEN REF ANNUAL REVIEW Reviewed by. Date. Date INTENDED USE

PRINCIPLE SPECIMEN REF ANNUAL REVIEW Reviewed by. Date. Date INTENDED USE SYNCHRON System(s) Chemistry Information Sheet Copyright 2013 Beckman Coulter, Inc. Microalbumin REF 475100 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by Date Reviewed by Date PRINCIPLE INTENDED

More information

Automation In Life Sciences and Diagnostics Applications

Automation In Life Sciences and Diagnostics Applications Automation In Life Sciences and Diagnostics Applications Pedro Diaz Director of Research Beckman Coulter Life Sciences February 20-22, 2013 Orlando World Marriott Center Orlando, Florida USA Beckman Coulter

More information

C-Chip DHC-N01 Disposable Hemocytometer

C-Chip DHC-N01 Disposable Hemocytometer INSTRUCTIONS www.incyto.com C-Chip DHC-N01 Disposable Hemocytometer System Neubauer Improved Ordering Information Worldwide Tel : +82-2-3787-196, 5 Fax : +82-2-537-269 E-Mail : sales@incyto.com Domestic(Korea)

More information

Recommendations For Serum Free Light Chains (SFLC) Measurement In Routine Laboratories

Recommendations For Serum Free Light Chains (SFLC) Measurement In Routine Laboratories ROYAL PRINCE ALFRED HOSPITAL A tradition of excellence since 1882 Recommendations For Serum Free Light Chains (SFLC) Measurement In Routine Laboratories Louise Wienholt Laboratory Manager Royal Prince

More information

Freelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies

Freelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies Freelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies Montgomery Lobe, MD, and Donald Pasquale, MD Abstract Monoclonal gammopathies are characterized by production of monoclonal

More information

Establishing Chemistry QC Ranges

Establishing Chemistry QC Ranges Chemistry Guideline for Establishing New Control Lot Means and Quality Control (QC) Ranges Through Parallel Testing and Historic Coefficient of Variation (%CV h ) Authored by Kurt Michael and Paul Richardson

More information

ARTICLES IMPACT STATEMENT ... September : JALM 211. Hassan Bayat, 1 Sten A. Westgard, 2 and James O.

ARTICLES IMPACT STATEMENT ... September : JALM 211. Hassan Bayat, 1 Sten A. Westgard, 2 and James O. Planning Risk-Based Statistical Quality Control Strategies: Graphical Tools to Support the New Clinical and Laboratory Standards Institute C24-Ed4 Guidance Hassan Bayat, 1 Sten A. Westgard, 2 and James

More information

S1725 Method Validation and Verification: Case Studies and Laboratory Challenges

S1725 Method Validation and Verification: Case Studies and Laboratory Challenges S1725 Method Validation and Verification: Case Studies and Laboratory Challenges James H. Nichols, PhD, D(ABCC) Lauren N. Person, DO, MPH, FCAP Objectives Identify the difference between method validation

More information

Original Article. A Novel Automated Slide-Based Technology for Visualization, Counting, and Characterization of the Formed Elements of Blood

Original Article. A Novel Automated Slide-Based Technology for Visualization, Counting, and Characterization of the Formed Elements of Blood Original Article A Novel Automated Slide-Based Technology for Visualization, Counting, and Characterization of the Formed Elements of Blood A Proof of Concept Study James W. Winkelman, MD; Milenko J. Tanasijevic,

More information

PDGFRB FISH PRODUCT DATASHEET. Proprietary Name: PDGFRB FISH for Gleevec Eligibility in Myelodysplastic Syndrome/Myeloproliferative Disease (MDS/MPD)

PDGFRB FISH PRODUCT DATASHEET. Proprietary Name: PDGFRB FISH for Gleevec Eligibility in Myelodysplastic Syndrome/Myeloproliferative Disease (MDS/MPD) PDGFRB FISH PRODUCT DATASHEET Proprietary Name: PDGFRB FISH for Gleevec Eligibility in Myelodysplastic Syndrome/Myeloproliferative Disease (MDS/MPD) Established Name: PDGFRB FISH for Gleevec in MDS/MPD

More information

Application Note for Gentian Cystatin C Immunoassay on. ABX Pentra 400 1, Horiba Medical 1 v03en-june 2011

Application Note for Gentian Cystatin C Immunoassay on. ABX Pentra 400 1, Horiba Medical 1 v03en-june 2011 Page 1 of 5 Application Note for Gentian Cystatin C Immunoassay on For in vitro diagnostic use only ABX Pentra 400 1, Horiba Medical 1 v03en-june 2011 Intended Use The Gentian Cystatin C Immunoassay is

More information

Plan Subject Index Number Section Subsection Category Contact Last Revised References Applicable To Detail PRINCIPLE:

Plan Subject Index Number Section Subsection Category Contact Last Revised References Applicable To Detail PRINCIPLE: Subject Quality Assurance for Laboratory Testing Index Number Lab-0135 Section Laboratory Subsection Laboratory - General Category Departmental Contact Nancy Ekern Last Revised 7/27/2017 References Required

More information

FER PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

FER PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE IMMAGE Immunochemistry Systems Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Ferritin REF 447160 (150 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by:

More information

ACTG Laboratory Technologist Committee Revised Version 2.0 ACTG Lab Man CD38 Quantitation 07 May 2004

ACTG Laboratory Technologist Committee Revised Version 2.0 ACTG Lab Man CD38 Quantitation 07 May 2004 1. Principle Flow Cytometric quantitation of CD38 expression on CD8+ T lymphocytes The purpose of this assay is to quantitate the surface expression of the CD38 molecule on CD8 positive T lymphocytes.

More information

Pre-analytics in coagulation lab: why struggle for better results?

Pre-analytics in coagulation lab: why struggle for better results? Pre-analytics in coagulation lab: why struggle for better results? Valdas Banys, MD, PhD Vilnius University Faculty of Medicine Vilnius University Hospital Santariskiu Klinikos, Center of Laboratory Medicine

More information

Validation of Platelet Counting Accuracy With the Celltac F Automated Hematology Analyzer

Validation of Platelet Counting Accuracy With the Celltac F Automated Hematology Analyzer Automated Methods & Management in Chemistry, 25 (25), no. 4, 235 239 c 25 Validation of Platelet Counting Accuracy With the Celltac F Automated Hematology Analyzer Yutaka Nagai, 1 Hiroshi Kondo, 2 and

More information

Forensic News. FAS Corner April The Maximizing Data Quality Series Part 2: DNA Quantitation

Forensic News. FAS Corner April The Maximizing Data Quality Series Part 2: DNA Quantitation The Maximizing Data Quality Series Part 2: DNA Quantitation (Editor's Note: This is part of an ongoing series of articles focusing on maximizing data quality throughout the HID workflow. Part 1 on DNA

More information

SAMPLE. Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline

SAMPLE. Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline April 2003 Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline This document provides guidance for characterizing the linearity of a method during

More information

CASE-STUDY- VALIDATION of PCR based methodology. Beata Surmacz-Cordle Senior Analytical Development Scientist

CASE-STUDY- VALIDATION of PCR based methodology. Beata Surmacz-Cordle Senior Analytical Development Scientist CASE-STUDY- VALIDATION of PCR based methodology Beata Surmacz-Cordle Senior Analytical Development Scientist UK RMP Pluripotent Stem Cell Platform Validation Workshop 2 nd June 2016 RT-qPCR assay for detection

More information

MyBioSource.com. Human Vitamin K2 ELISA USER INSTRUCTION

MyBioSource.com. Human Vitamin K2 ELISA USER INSTRUCTION Human Vitamin K2 ELISA USER INSTRUCTION Cat.No MBS163021 Standard Curve Range: 5ng/ml - 1000ng/ml Sensitivity: 2.52ng/ml Size: 96 wells Storage: Store the reagents at 2-8 C. For over 6-month storage refer

More information

ALPHA CrossLaps ELISA

ALPHA CrossLaps ELISA ALPHA CrossLaps ELISA For the quantification of degradation products of C-terminal telopeptides of Type-l collagen in human urine The ALPHA CrossLaps ELISA kit is For Research Use Only. Not for use in

More information

Strengthening Laboratory Management Toward Accreditation. Module 6: Quality Assurance

Strengthening Laboratory Management Toward Accreditation. Module 6: Quality Assurance Strengthening Laboratory Management Toward Accreditation Module 6: Quality Assurance Key Message My lab assures accurate and reliable testing processes. Desired Outcome Consistently accurate and reliable

More information

MyBioSource.com. Human Osteoprotegerin ELISA USER INSTRUCTION

MyBioSource.com. Human Osteoprotegerin ELISA USER INSTRUCTION Human Osteoprotegerin ELISA USER INSTRUCTION Cat.No MBS162588 Standard Curve Range: 0.05ng/ml - 15ng/ml Sensitivity: 0.023ng/ml Size: 96 wells Storage: Store the reagents at 2-8 C. For over 6-month storage

More information

Manual For Blood Cells Atlas Morphology Download

Manual For Blood Cells Atlas Morphology Download We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with manual for blood cells

More information

UNRIVALED SIMPLICITY. Exceptional Ease of Use. The STAR brings new meaning to the word simple

UNRIVALED SIMPLICITY. Exceptional Ease of Use. The STAR brings new meaning to the word simple UNRIVALED SIMPLICITY The QBC STAR Centrifugal Hematology System is the simplest solution for in-office CBC testing. An innovative approach employing dry hematology reagents instead of the bulky liquid

More information

For In Vitro Diagnostic Use. Rx Only. Reviewed by Date Reviewed by Date

For In Vitro Diagnostic Use. Rx Only. Reviewed by Date Reviewed by Date IMMAGE Immunochemistry Systems Chemistry Information Sheet 2017 Beckman Coulter, Inc. All rights reserved. LAM Lambda Light Chain 446470 (150 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Rx Only Reviewed

More information

Blood and Tissue Parasites Issued by: LABORATORY MANAGER Original Date: March 13, 2000 Approved by: Laboratory Director Review Date:

Blood and Tissue Parasites Issued by: LABORATORY MANAGER Original Date: March 13, 2000 Approved by: Laboratory Director Review Date: Section: Policy # MI\PAR\11\01\v01 Page 1 of 5 Subject Title: Laboratory Procedures for Blood and Tissue Parasites Issued by: LABORATORY MANAGER Original Date: March 13, 2000 Approved by: Laboratory Director

More information

MyBioSource.com. Rat Hydroxyproline ELISA USER INSTRUCTION

MyBioSource.com. Rat Hydroxyproline ELISA USER INSTRUCTION Rat Hydroxyproline ELISA USER INSTRUCTION Cat.No MBS162747 Standard Curve Range: 10ng/L - 4000ng/L Sensitivity: 4.99ng/L Size: 96 wells Storage: Store the reagents at 2-8 C. For over 6-month storage refer

More information

Performance Evaluation of the Coulter LH 750 Hematology Analyzer

Performance Evaluation of the Coulter LH 750 Hematology Analyzer ISLH Laboratory Hematology 7:217 228 2001 Carden Jennings Publishing Co., Ltd. Official Publication Performance Evaluation of the Coulter LH 750 Hematology Analyzer TRACEY FERNANDEZ, LYNN BESSERT DOMACK,

More information

So You Want to Develop a Test? Navigating the Regulatory Waters of Laboratory Developed Testing

So You Want to Develop a Test? Navigating the Regulatory Waters of Laboratory Developed Testing So You Want to Develop a Test? Navigating the Regulatory Waters of Laboratory Developed Testing Professor of Pathology, Microbiology, and Immunology Associate Medical Director of Clinical Operations Medical

More information

TELE-HEMATOLOGY: CRITICAL DETERMINANTS FOR SUCCESSFUL IMPLEMENTATION

TELE-HEMATOLOGY: CRITICAL DETERMINANTS FOR SUCCESSFUL IMPLEMENTATION Blood First Edition From Paper, www.bloodjournal.org prepublished by online guest on September July 4, 2018. 11, For 2003; personal DOI use 10.1182/blood-2003-05-1615 only. TELE-HEMATOLOGY: CRITICAL DETERMINANTS

More information

Please consult the Product Package Insert before running the test

Please consult the Product Package Insert before running the test Please consult the Product Package Insert before running the test Sample Collection, Preparation, Storage and Volume Q. What type of blood sample should be used with the PIFA Heparin/PF4 Rapid Assay? A.

More information

SAMPLE. Evaluation of Total Analytical Error for Quantitative Medical Laboratory Measurement Procedures

SAMPLE. Evaluation of Total Analytical Error for Quantitative Medical Laboratory Measurement Procedures 2nd Edition EP21 Evaluation of Total Analytical Error for Quantitative Medical Laboratory Measurement Procedures This guideline provides manufacturers and end users with an understanding of concepts related

More information

Prepublication Requirements

Prepublication Requirements Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals

More information

Test Bulletin. If a false positive test result is suspected, please contact ACL Client Services at for further assistance.

Test Bulletin. If a false positive test result is suspected, please contact ACL Client Services at for further assistance. Test Bulletin Pregnancy Test Serum Qualitative (Test Order Code SHCG) Update While rare, serum HCG tests may give a false positive or erroneous results in patients who have circulating heterophile antibodies.

More information

The International Haemostasis External Quality Control Program

The International Haemostasis External Quality Control Program The International Haemostasis External Quality Control Program Intended use of Quality Control Primary Purpose of the Clinical Laboratory To produce accurate results that will correctly diagnose and interpret

More information

The Simple Solution for CBC Testing

The Simple Solution for CBC Testing QBC STAR Centrifugal Hematology Analyzer The Simple Solution for CBC Testing Diagnostics Innovative Solutions for a Healthier World UNRIVALED SIMPLICITY The QBC STAR Centrifugal Hematology System is the

More information

Practical Guide to Running Controls

Practical Guide to Running Controls Practical Guide to Running Controls Internal quality control Introduction In addition to the competenceof the lab managerand the technical validation, the use and proper management of quality control (IQC,

More information

BC Auto Hematology Analyzer. A CUTE 5-part

BC Auto Hematology Analyzer. A CUTE 5-part BC-5000 Auto Hematology Analyzer A CUTE 5-part Why do we need 5-part hematology analyzers? WBC differential: 3-part WBC differential: 5-part Lymphocyte Mid-size cell? Eosinophil Basophil Neutrophil DIFF

More information

ASVCP quality assurance guidelines: control of general analytical factors in veterinary laboratories

ASVCP quality assurance guidelines: control of general analytical factors in veterinary laboratories Veterinary Clinical Pathology ISSN 0275-6382 SPECIAL REPORT ASVCP quality assurance guidelines: control of general analytical factors in veterinary laboratories Bente Flatland 1, Kathy P. Freeman 2, Kristen

More information

Biochemical Genetics Laboratory Hospital Marie Jackson Consultant Clinical Scientist

Biochemical Genetics Laboratory Hospital Marie Jackson Consultant Clinical Scientist Biochemical Genetics Laboratory Viapath @Guys Hospital Marie Jackson Consultant Clinical Scientist Measurement uncertainty Produced document stating our approach to measurement uncertainty in Biochemical

More information

Cost Accounting The Foundation of Management Control

Cost Accounting The Foundation of Management Control Cost Accounting The Foundation of Management Control Management Activities One can view the management activities of all healthcare organizations, from the largest tertiary hospital system to the smallest

More information

Brad Dickinson MSc. MIBMS Chief Biomedical Scientist Leeds Anticoagulant Service

Brad Dickinson MSc. MIBMS Chief Biomedical Scientist Leeds Anticoagulant Service Brad Dickinson MSc. MIBMS Chief Biomedical Scientist Leeds Anticoagulant Service Leeds Teaching Hospitals Currently undergoing a Service Development Project Initiated PoCT in Clinics in 2012 Roche Coaguchek

More information

BC Auto Hematology Analyzer. A CUTE 5-part

BC Auto Hematology Analyzer. A CUTE 5-part BC-5150 Auto Hematology Analyzer A CUTE 5-part Why do we need 5-part hematology analyzers? WBC differential: 3-part WBC differential: 5-part Lymphocyte Mid-size cell? Eosinophil Basophil Neutrophil DIFF

More information

VALIDATION OF AN ERYTHROCYTE SEDIMENTATION RATE ANALYZER WITH MODIFIED WESTERGREN METHOD

VALIDATION OF AN ERYTHROCYTE SEDIMENTATION RATE ANALYZER WITH MODIFIED WESTERGREN METHOD VALIDATION OF AN ERYTHROCYTE SEDIMENTATION RATE ANALYZER WITH MODIFIED WESTERGREN METHOD Asha Patil, Deepak Nayak M., Sushma V. Belurkar, SeemitrVerma 1. Assistant Professor, Department of Medical Laboratory

More information